ANEMIA IN PREGNANCY : MCQS AND IMPORTANT MCQS By DR MARIA RAFI

Image
  1.  A 30-year-old pregnant female is undergoing routine blood tests . Pregnancy is associated with an increase in which of the following? A) Mean Cell Hemoglobin Concentration (MCHC) B) Serum ferritin concentration C) Hematocrit D) Total Iron Binding Capacity (TIBC) ✅ Answer: D) Total Iron Binding Capacity (TIBC) Explanation: Pregnancy leads to increased TIBC due to higher transferrin synthesis to compensate for increased iron demand. Serum ferritin and iron decrease due to increased iron utilization. Hematocrit reduces due to physiological hemodilution , not an actual decrease in RBC mass. DR MARIA RAFI ;923324747587 2.  A 28-year-old female, para 2+0 , presents with Hb 7 g/dL . What is the next best investigation? A) Hb electrophoresis   B) Total iron-binding capacity (TIBC) C) MCV and peripheral smear ✅ D) Serum iron Answer: A) Hb electrophoresis Explanation: The first step is to check MCV (Mean Corpuscular Volume) to classify anemia...

Solid organ transplantation in pregnancy (tog 9 oct 2015) by MH ACADEMY by Dr Maria Rafi


Pregnancy and  Renal Transplant Recipients

πŸ“Œ Importance of Prepregnancy Counselling

  • Increased maternal morbidity and mortality in women with medical comorbidities without prepregnancy counselling.
  • Safe and effective contraception is essential until prepregnancy counselling occurs.

Timing for Conception Post-Transplant

  • Conception is discouraged within the first year post-transplant due to:
    • Higher doses of immunosuppressants.
    • Difficulty in assessing graft stability.
    • Acute rejection risk: 10–15%, especially in recipients under 45 years.

🩺 Assessment of Risks Based on Graft Function

  • Stable graft function (1 year post-transplant) reduces pregnancy risks.
  • Women with normal estimated glomerular filtration rate (eGFR):
    • No conclusive evidence of increased risk of graft rejection or deterioration.
  • Conditions impacting risks:
    • Diabetes-related nephropathy:
      • Risk of neuropathy and retinopathy.
      • Poor diabetic control increases pregnancy risk.
    • Lupus:
      • Antibody profile influences pregnancy risk.

πŸ’Š Medications to Discontinue Prior to Pregnancy

  • Teratogenic medications to stop:
    • Mycophenolate mofetil:
      • Switch to azathioprine 3 months before conception.
      • Recommended wash-out period: 3 months.
      • Azathioprine is considered safe and does not deteriorate graft function.
    • ACE inhibitors (ACEi) and angiotensin receptor antagonists:
      • Switch to alternative antihypertensives.
    • Statins:
      • Discontinue before conception.

🀰 Effects of Renal Transplantation on Pregnancy

  • Prepregnancy renal function predicts outcomes:
    • Poor pregnancy outcomes (e.g., preterm birth, neonatal death) are linked to higher creatinine levels.
  • Hypertension:
    • Present in >50% of renal transplant recipients.
    • 16% of normotensive women pre-pregnancy develop hypertension during pregnancy.
    • Associated risks:
      • Pre-eclampsia.
      • Fetal growth restriction.
      • Preterm delivery.
      • Neonatal intensive care admission.
      • Perinatal death.
  • Proteinuria:
    • Prepregnancy protein loss >1 g/day increases maternal renal function loss risk postpartum.
    • Adds complexity to diagnosing pre-eclampsia.

🌱 Impact of Pregnancy on Renal Transplants

  • Studies show no significant difference in graft survival between pregnant and nulliparous recipients:
    • 5-year unadjusted graft survival rate: Pregnant (89%) vs. controls (85.3%).
    • Acute rejection rate during pregnancy: 4.2%.
    • UK data show graft rejection during pregnancy: <2%.
  • Treatment of rejection:
    • Corticosteroids and optimization of tacrolimus/ciclosporin.

🩺 Antenatal Management

  • Multidisciplinary care:
    • Obstetrician, transplant team, and midwifery support.
  • Monitoring:
    • Renal function: Monthly checks.
    • Tacrolimus/ciclosporin blood levels: Regularly monitored.
    • Blood pressure: Maintain <140/90 mmHg.
  • Erythropoietin requirements:
    • In normal pregnancy, erythropoietin concentration increases 2–4 fold.
    • This increase may not occur even in the absence of significant transplant dysfunction.
    • Clinicians should consider treatment with erythropoietin-stimulating agents during pregnancy in iron-replete, anaemic women.
  • Screening and scans:
    • Routine 12-week and 20-week scans.
    • Serological screening for chromosomal trisomy:
      • Affected by renal excretion of Ξ²-human chorionic gonadotrophin (Ξ²-hCG).
      • Significant renal dysfunction may lead to false positive results.
      • If high-risk results are observed with impaired renal function and raised Ξ²-hCG, consider:
        • Detailed ultrasound screening.
        • Noninvasive prenatal testing (NIPT).
  • Fetal growth scans:
    • Conducted at 26–28 weeks and 32–34 weeks due to the risk of growth restriction.
  • πŸ‘Ά Intrapartum Management
  • Preferred mode of delivery:
    • Vaginal delivery unless contraindicated.
  • Caesarean delivery:
    • Risk of trauma to renal graft: 1–2%.
    • Requires multidisciplinary assessment.
  • Steroid use:
    • Prednisolone >7.5 mg/day: IV hydrocortisone during labor.

πŸ₯ Postpartum Management

  • Blood pressure:
    • Target: <140/90 mmHg.
    • Safe antihypertensives for breastfeeding: Enalapril.
  • Contraception:
    • Progesterone-only pill, Mirena intrauterine system






Comments

Popular posts from this blog

ANEMIA IN PREGNANCY : MCQS AND IMPORTANT MCQS By DR MARIA RAFI

IMPORTANT MCQS OF 2024for imm ; fcps ; mcps ; IMM (MUST DO BEFORE EXAM DAY )

IMPORTANT MCQS FILE 3 (70 mcqs) : IMM ; MCPS ; FCPS